07-Oct-2022
New Trinity Delta Research Report – New data draws attention to promising fibrosis assets
29-Jun-2022
New Trinity Delta Research Report – All the ingredients for success now in place
15-Jun-2022
New Trinity Delta Lighthouse Research Report – Jazz Pharmaceuticals $5m milestone triggered
07-Jun-2022
New Trinity Delta Lighthouse Research Report – £34.3m raise extends runway through key data points
30-Mar-2022
New Trinity Delta Research Report – RXC008 nominated as GI-ROCK drug candidate
17-Feb-2022
New Trinity Delta Research Report – Building on an impressive track-record
27-Jan-2022
New Trinity Delta Research Report – FY21 results: a year of continuing delivery
12-Oct-2021
Trinity Delta – R&D update: RXC004 and RXC007 in the spotlight
21-Sep-2021
New Trinity Delta Research Report – ESMO 2021: RXC004 monotherapy Phase I study results
07-Sep-2021
New Trinity Delta Research Report – ‘All that Jazz: $3m milestone boosts cash and confidence’